國立虎尾科技大學 |

Cancer vaccines

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Cancer vaccines/ edited by Natalia Savelyeva, Christian Ottensmeier.
other author:	Savelyeva, Natalia.
Published:	Cham :Springer International Publishing : : 2017.,
Description:	vii, 210 p. :ill., digital ; : 24 cm.;
Contained By:	Springer eBooks
Subject:	Cancer - Vaccination. -
Online resource:	http://dx.doi.org/10.1007/978-3-319-23910-1
ISBN:	9783319239101

Cancer vaccines
Cancer vaccines[electronic resource] /edited by Natalia Savelyeva, Christian Ottensmeier. - Cham :Springer International Publishing :2017. - vii, 210 p. :ill., digital ;24 cm. - Current topics in microbiology and immunology,v.4050070-217X ;. - Current topics in microbiology and immunology ;v.355..

New Approaches in Immunotherapy for the treatment of Lung Cancer -- Novel approaches for vaccination against HPV-induced cancers -- Tapping the potential of DNA Delivery with Electroporation for Cancer Immunotherapy -- Targeted immunotherapy designed to treat Muc1-expressing solid tumour -- Chimeric DNA vaccines: an effective way to overcome immune tolerance -- Linked CD4 T-cell help: broadening immune attack against cancer by vaccination -- mRNA cancer vaccines - Messages that prevail -- The Use of Anti-CD40 mAb in Cancer.

This volume focuses on the laboratory and clinical experience with targeting viral onco-antigens, while also reviewing the approaches to targeting self-cancer antigens in cancers of non-viral origin, where self-tolerance has been a challenge. It emphasizes the importance of selecting the right vaccine platform to induce a successful immune response against cancer antigens. In addition, the volume discusses the advances made with genetic vaccines, including recent advances with DNA vaccines and the rapid transition of mRNA vaccines from the laboratory to bedside. The new avenues opening up for cancer immunotherapy underline the importance of combinational approaches using cancer vaccines with costimulatory antibodies, which may dramatically improve cancer treatment. This book is intended for all translational researchers and clinicians who aspire to develop novel vaccination approaches for cancer patients with unmet clinical needs.

ISBN: 9783319239101

Standard No.: 10.1007/978-3-319-23910-1doiSubjects--Topical Terms:

1198567
Cancer
--Vaccination.

LC Class. No.: RC271.I45

Dewey Class. No.: 616.9940655

Cancer vaccines
LDR:02496nam a2200325 a 4500 001 922756
003 DE-He213
005 20170710183104.0
006 m d
007 cr nn 008maaau
008 190625s2017 gw s 0 eng d
020 $a 9783319239101 $q (electronic bk.)
020 $a 9783319239095 $q (paper)
024 7 $a 10.1007/978-3-319-23910-1 $2 doi
035 $a 978-3-319-23910-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RC271.I45
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.9940655 $2 23
090 $a RC271.I45 $b C215 2017
245 0 0 $a Cancer vaccines $h [electronic resource] / $c edited by Natalia Savelyeva, Christian Ottensmeier.
260 $a Cham : $c 2017. $b Springer International Publishing : $b Imprint: Springer,
300 $a vii, 210 p. : $b ill., digital ; $c 24 cm.
490 1 $a Current topics in microbiology and immunology, $x 0070-217X ; $v v.405
505 0 $a New Approaches in Immunotherapy for the treatment of Lung Cancer -- Novel approaches for vaccination against HPV-induced cancers -- Tapping the potential of DNA Delivery with Electroporation for Cancer Immunotherapy -- Targeted immunotherapy designed to treat Muc1-expressing solid tumour -- Chimeric DNA vaccines: an effective way to overcome immune tolerance -- Linked CD4 T-cell help: broadening immune attack against cancer by vaccination -- mRNA cancer vaccines - Messages that prevail -- The Use of Anti-CD40 mAb in Cancer.
520 $a This volume focuses on the laboratory and clinical experience with targeting viral onco-antigens, while also reviewing the approaches to targeting self-cancer antigens in cancers of non-viral origin, where self-tolerance has been a challenge. It emphasizes the importance of selecting the right vaccine platform to induce a successful immune response against cancer antigens. In addition, the volume discusses the advances made with genetic vaccines, including recent advances with DNA vaccines and the rapid transition of mRNA vaccines from the laboratory to bedside. The new avenues opening up for cancer immunotherapy underline the importance of combinational approaches using cancer vaccines with costimulatory antibodies, which may dramatically improve cancer treatment. This book is intended for all translational researchers and clinicians who aspire to develop novel vaccination approaches for cancer patients with unmet clinical needs.
650 0 $a Cancer $x Vaccination. $3 1198567
650 1 4 $a Biomedicine. $3 593880
650 2 4 $a Cancer Research. $3 668358
650 2 4 $a Immunology. $3 592892
650 2 4 $a Vaccine. $3 782685
700 1 $a Savelyeva, Natalia. $3 1198565
700 1 $a Ottensmeier, Christian. $3 1198566
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
830 0 $a Current topics in microbiology and immunology ; $v v.355. $3 882363
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-23910-1
950 $a Biomedical and Life Sciences (Springer-11642)